Skip to content
  • Sunday, 26 July 2026
  • 1:46 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease
Pharmaceutical R&D

Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease

Teuku Ryan Jul 24, 2026 0

Evogene and ELEO have officially announced a significant scientific collaboration poised to accelerate the discovery and development of novel oral…

Read More
Pharmaceutical R&D

Samsung Biologics Accelerates Global Expansion with Strategic US Acquisition and PolyPeptide Deal

Teuku Ryan Jul 22, 2026 0

South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has embarked on a significant phase of global expansion, marked…

Read More
Biotech & Genetic Research

Biotech Sector Sees Major Leaps in Multiomics, Cell Research Accessibility, and Strategic Leadership

Jia Lissa Jul 22, 2026 0

The global biotechnology landscape witnessed a week of pivotal advancements, marked by significant strides in multiomics research, enhanced accessibility to…

Read More
Laboratory Automation & Robotics

Navigating the New Frontier: American Biotech’s Strategic Imperatives Amidst Global Competition and Shifting Investment Tides

Lana Keisha Jul 21, 2026 0

For several years, the landscape for American biotechnology firms has grown increasingly challenging, with success becoming a more elusive commodity.…

Read More
Laboratory Automation & Robotics

Arrowfly Emerges as the New Corporate Identity for WTWH Media, Signaling Strategic Expansion and Market Consolidation

Lana Keisha Jul 20, 2026 0

Cleveland, Ohio – In a significant corporate development signaling a strategic evolution and a unified market approach, WTWH Media, the…

Read More
Pharmaceutical R&D

MSD Secures Landmark Approval for First Oral PCSK9 Inhibitor, Ushering in New Era for Cholesterol Management and Strategic Diversification

Teuku Ryan Jul 19, 2026 0

The pharmaceutical landscape has been significantly reshaped with MSD (Merck & Co.) achieving a monumental victory: the US Food and…

Read More
Laboratory Automation & Robotics

WTWH Media Rebrands to Arrowfly, Signaling Strategic Evolution in B2B Information and Events Landscape

Lana Keisha Jul 13, 2026 0

Cleveland-based WTWH Media, a prominent and diversified entity within the business-to-business (B2B) media and events sector, officially announced its corporate…

Read More
Pharmaceutical R&D

Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases

Teuku Ryan Jun 27, 2026 0

Immunai, a leading artificial intelligence (AI) company specializing in immune system analysis, and Boehringer Ingelheim, a global biopharmaceutical giant, have…

Read More
Pharmaceutical R&D

Eli Lilly and Oura Health Forge Strategic Alliance to Pioneer Integrated Obesity Care

Teuku Ryan Jun 25, 2026 0

The landscape of obesity treatment is undergoing a profound transformation, moving beyond purely pharmaceutical interventions to embrace a holistic ecosystem…

Read More
Pharmaceutical R&D

Voro Therapeutics and Alloy Therapeutics Forge Strategic Partnership to Revolutionize Tumour-Selective T-Cell Engager Therapies

Teuku Ryan Jun 20, 2026 0

Voro Therapeutics and Alloy Therapeutics have announced a significant strategic research partnership aimed at developing a new generation of masked…

Read More

Posts pagination

1 2 … 5
Staying Ahead in the AI Revolution: Ten Essential Newsletters for 2026Unlocking Nature’s Proton Highway: Scientists Pinpoint Molecular Key to Biological Charge TransportAI Agents Stumble in Scientific Reasoning, Failing to Adapt to Experimental EvidenceImmuto Scientific Pioneers a Step Change in Protein Structure Throughput by Integrating AI and Mass Spectrometry
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ